N
Norman M Kaplan
Researcher at University of Texas Southwestern Medical Center
Publications - 371
Citations - 12992
Norman M Kaplan is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Blood pressure & Plasma renin activity. The author has an hindex of 49, co-authored 369 publications receiving 12811 citations. Previous affiliations of Norman M Kaplan include George Washington University & Princess Alexandra Hospital.
Papers
More filters
Journal ArticleDOI
The Deadly Quartet: Upper-Body Obesity, Glucose Intolerance, Hypertriglyceridemia, and Hypertension
TL;DR: The evidence that upper-body obesity, as usually induced by caloric excess in the presence of androgens, mediates problems with hypertension, diabetes, and hypertriglyceridemia by way of hyperinsulinemia is examined.
Journal ArticleDOI
The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure
Aram V. Chobanian,Michael H. Alderman,Vincent DeQuattro,Edward D. Frohlich,Ray W. Gifford,Martha N. Hill,Norman M Kaplan,Herbert G. Langford,Michael A. Moore,William A. Nickey,Jerome G. Porush,Gerald E. Thomson,Mary Winston,Harriet P. Dustan,Iqbal Krishan,Marvin Moser,Jeffrey A. Cutler,Michael J. Horan,Gerald H. Payne,Edward J. Roccella,Stephen M. Weiss +20 more
TL;DR: This report updates findings of previous reports in several respects: it broadens the step-care approach to provide more flexibility for clinicians; encourages greater patient involvement in the treatment program; emphasizes a consideration of the quality of life in the management of patients; and addresses the cost of care.
Upper-Body Obesity, Glucose Intolerance, Hypertriglyceridemia, and Hypertension
TL;DR: Evidence is examined that upper-body obesity, as usually induced by caloric excess in the presence of androgens, mediates problems with hypertension, diabetes, and hypertriglyceridemia by way of hyperinsulinemia.
Journal ArticleDOI
Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention
Clive Rosendorff,Henry R. Black,Christopher P. Cannon,Bernard J. Gersh,Joel M. Gore,Joseph L. Izzo,Norman M Kaplan,Christopher M. O'Connor,Patrick T. O'Gara,Suzanne Oparil +9 more
TL;DR: The optimal choice of antihypertensive agents remains controversial, and there are only partial answers to important questions in the treatment of hypertension in the prevention and management of ischemic heart disease (IHD).
Journal ArticleDOI
The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure
Robert M. Carey,Jeffrey A. Cutler,William T. Friedewald,Norman Gant,Stephen B. Hulley,James Iacono,M. H. Maxwell,Donald McNellis,Gerald H. Payne,Alvin P. Shapiro,Stephen M. Weiss,Harriet P. Dustan,Aram V. Chobanian,Bonita Falkner,Thomas F. Ferris,Edward D. Frohlich,Ray W. Gifford,Martha N. Hill,Michel Ibrahim,Norman M Kaplan,Ophelia Long,Harry Metcalf,Marvin Moser,William A. Nickey,H. Mitchell Perry,Gerald E. Thomson,Michael J. Horan,Edward J. Roccella,Ann E. Bowler,Frances W. Gillen +29 more
TL;DR: This report includes recommendations on the following topics: screening and referral procedures, classification according to BPs, use of nonpharmacologic therapies, revised stepped-care approach, management of mild hypertension, and management of BP in special groups, including blacks, children, and pregnant.